Definitive contract 75A50124C00002VAXART BIOSCIENCES INC
Overview
Award facts
- Net obligations
- $9.27M
- $9,271,191of $9.27M potential value
- Outlays (paid to date)
- $9.27M
- $9.27M paid of $9.27M obligated$9,271,191
- Period of performance
- Jan 12, 2024 to Oct 31, 2024
- Ended
- Modifications
- 3
- Latest action Feb 2, 2026
- Contract type
- Definitive contract
- PIID 75A50124C00002
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
CLINICAL TRIAL PLANNING ACTIVITIES FOR A PHASE 2B CLINICAL TRIAL THAT COMPARES VAXART'S XBB VACCINE CANDIDATE TO AN MRNA COMPARATOR TO EVALUATE EFFICACY FOR SYMPTOMATIC AND ASYMPTOMATIC DISEASE, SYSTEMIC AND MUCOSAL IMMUNE INDUCTION, AND ADVERSE
Dates and value
- Award date
- Signed on Jan 12, 2024
- Current value
- $9,271,191Base and exercised options
- Potential value (if all options are exercised)
- $9,271,191
Obligations by fiscal year of action
- FY2026: -$2 (de-obligation)
- FY2024: $9,271,193
Total across 2 fiscal years: $9,271,191
Net de-obligation in that fiscal year (obligations withdrawn).
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Feb 2, 2026. View on USAspending · Recipient on SAM.gov
Recipient
Business types and certifications
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded from
- Public health and social services emergency fundProgram activities075-0140Federal accounts (agency financial reports)
Place of performance
- Place of performance
- South San Francisco, San Mateo County, California 94080-6102
- Congressional district (place of performance)
- CA-15As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN42HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jan 12, 2024Base obligation at award: $9,271,193
- Latest action
- Feb 2, 2026 — CloseoutModification P00003; obligation change -$2; administrative: no change in scope or value
- Latest substantive action
- Jul 12, 2024 — Supplemental agreement (within scope)Modification P00002
- Actions by type
- Base award1
- Supplemental agreement (within scope)2
- Closeout1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$2
- Latest action: change in base and all options
- -$2
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A501
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A501
- Treasury accounts
- 075-2020/2024-0140-000
- Object classes
- 25.1: Advisory and assistance services
- Disaster or emergency funding (DEFC)
- N: Emergency P.L. 116-136
- COVID-19 supplemental obligations
- $9,271,191
- COVID-19 supplemental outlays
- $9,271,191